WST

West Pharmaceutical Services
D

WST

Arincen83/100B
413.00
USD
1.73
(0.42%)
Market Open
Last updated: · Delayed 15 min
Fair value379.45Plus+9%222Price 413.00531
Q4 FY2026 · Earnings report
EPS estimate 2.27Revenue estimate 825.22M
OverviewFinancialsForecastEarningsDividendsCompany

West Pharmaceutical Services return on equity (ROE)

West Pharmaceutical Services's return on equity is 21.52%: net income of 638.90M USD over the last twelve months on shareholders' equity of 2.97B USD.

Today
21.52%
Average, 5 years
20.73%
Low, 5 years
15.54%
High, 5 years
29.42%

ROE (return on equity) = net income (last 12 months) ÷ shareholders' equity = 638.90M ÷ 2.97B = 21.52%

ROE (return on equity)
Net income
Shareholders' equity

Each quarter's net income over its last four quarters, over the shareholders' equity at the quarter end.

What drives West Pharmaceutical Services's return on equity?

Net margin
16.1%
profit on each dollar of sales
Asset turnover
0.72×
sales on each dollar of assets
Equity multiplier
1.34×
assets on each dollar of equity
Return on equity
15.5%
FY2025
  • FY202516.1% × 0.72 × 1.34 = 15.5%
  • FY202417.0% × 0.79 × 1.36 = 18.4%
  • FY202320.1% × 0.77 × 1.33 = 20.6%
  • FY202220.3% × 0.80 × 1.35 = 21.8%
  • FY202123.4% × 0.85 × 1.42 = 28.3%

The DuPont breakdown, on each year-end's assets and equity, as the return on equity elsewhere on this page. A high equity multiplier means a small equity base: debt, or buybacks that return the equity to shareholders, lift the return on what is left.

ROE (return on equity) by year and by quarter

Fiscal yearPeriod endingROE (return on equity)Net incomeShareholders' equity
Today21.52%638.90M2.97B
FY202531 Dec 202515.54%493.70M3.18B
FY202431 Dec 202418.37%492.70M2.68B
FY202331 Dec 202320.60%593.40M2.88B
FY202231 Dec 202221.82%585.90M2.68B
FY202131 Dec 202128.34%661.80M2.34B
FY202031 Dec 202018.67%346.20M1.85B
FY201931 Dec 201915.36%241.70M1.57B
FY201831 Dec 201814.82%206.90M1.40B
FY201731 Dec 201711.77%150.70M1.28B
FY201631 Dec 201612.85%143.60M1.12B
FY201531 Dec 20159.34%95.60M1.02B
FY201431 Dec 201413.28%127.10M956.90M
FY201331 Dec 201312.39%112.30M906.40M
FY201231 Dec 201211.07%80.70M728.90M
FY201131 Dec 201111.53%75.50M654.90M
FY201031 Dec 201010.44%65.30M625.70M
FY200931 Dec 200912.54%72.60M579.10M
FY200831 Dec 200817.66%86.00M487.10M
FY200731 Dec 200714.57%70.70M485.30M
FY200631 Dec 200616.19%67.10M414.50M
FY200531 Dec 200513.67%45.60M333.50M
FY200431 Dec 20046.44%19.40M301.10M
FY200331 Dec 200312.38%31.90M257.60M
FY200231 Dec 20029.13%18.40M201.50M
FY200131 Dec 200111.09%19.60M176.80M
FY200031 Dec 20000.78%1.60M204.80M
FY199931 Dec 199916.74%38.70M231.20M
FY199831 Dec 19982.91%6.70M230.10M
FY199731 Dec 199715.99%44.40M277.70M
FY199631 Dec 19966.51%16.40M252.00M
FY199531 Dec 199511.29%28.70M254.10M
FY199431 Dec 199412.01%27.30M227.30M
FY199331 Dec 199311.96%22.50M188.10M
FY199231 Dec 199211.68%19.70M168.60M
FY199131 Dec 1991-5.57%-8.50M152.70M
FY199031 Dec 19902.44%4.30M176.10M
FY198931 Dec 198911.52%20.70M179.70M
FY198831 Dec 198810.15%17.40M171.40M
FY198731 Dec 19878.79%13.70M155.80M
FY198631 Dec 198612.24%17.00M138.90M
FY198531 Dec 198512.55%15.00M119.50M

Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.

See also:P/E ratio,Market cap,P/S ratio,Dividend yield,Debt to equity,Current ratio,All ratios

Common questions about West Pharmaceutical Services's ROE

Source: Financial Modeling Prep